Curaleaf Holdings

Curaleaf New Jersey Launches State's First and Only Line of Strain ...

CURA Profile

  • Sector: Process Industries
  • Industry: Agricultural Commodities/Milling

Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.

Recent News

Curaleaf Completes New $50 Million Revolving Credit Facility

The new credit facility provides Curaleaf enhanced capital structure flexibility and a lower cost of capital to support future growth WAKEFIELD, Mass., Jan. 11, 2021 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF)(“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company has successfully completed a new $50 million, three-year secured revolving credit […]

Curaleaf Announces Pricing of Offering of Subordinate Voting Shares

WAKEFIELD, Mass., Jan. 7, 2021 /CNW/ – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, announced today the pricing of its previously announced overnight marketed offering (the “Offering”) of an aggregate of 16,500,000 subordinate voting shares (the “Offered Securities”) at a price of C$16.70  per share for total […]

Curaleaf Provides Update on Executive Stock Ownership

— Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, commented today regarding a recent executive stock ownership change. Mr. Joseph Lusardi, Curaleaf Chief Executive Officer, exercised options to purchase approximately 900,114 subordinate voting shares (SVS) of Curaleaf common stock on December 7, 2020. This latest options activity brings […]


Something went wrong. Please refresh the page and/or try again.